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May 20121542 Abstractsgroup T. The 5-year event-free rates were 67.4%  8.2% in group U and
57.7% 10.9% in group P vs 95.04% 4.9% in group T (group T vs group
U: P .001; group U vs group P: P .96; group P vs group T: P .0004).
False lumen status (patent or ULP; P  .29), maximum aortic diameter at
onset (P  .001), and patient age (P  .0069) all were predictors of late
aortic events.
Comment:Widespread availability of thoracic endografts has added to
the controversy about how to manage patients with acute aortic dissection.
At one extreme is to use medical management for all patients except those
with obvious complications of rupture ormalperfusion. At the other extreme
is placement of an endograft for all acute type B aortic dissections regardless
of the presence of complications. A middle ground is to try to determine
which patients with acute type B aortic dissection are at greatest risk for late
aortic events such as late rupture or progressive dilation. Data such as this are
helpful in trying to determine whether a middle ground for acute treatment
of patients with acute aortic dissection is reasonable.
Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
Philadelphia, PA: Elsevier; 2012; with permission.
Long-term Outcome After Additional Catheter-Directed Thromboly-
sis Versus Standard Treatment for Acute Iliofemoral Deep Vein
Thrombosis (the CaVen T Study): A Randomised Controlled Trial
Enden T, Haig Y Klow N-E; CaVen T, Study Group. Lancet 2012;379:
31-38.
Conclusion:Catheter-directed thrombolysis (CDT) should be consid-
ered in patients with proximal deep vein thrombosis (DVT) and a low risk of
bleeding.
Summary: Patients with symptomatic DVT of the popliteal and more
proximal veins have up to a 50% incidence of some degree of post-thrombotic
syndrome (PTS; Prandoni P et al. Ann Intern Med 2004;141:249-56). A
recent systematic review suggested thrombus removal lowers the incidence
of PTS (Watson LI et al. Cochrane Database Syst Rev 2004;4:CD002783).
The Catheter-Directed Venous Thrombolysis Study evaluated if the addi- Pion of CDT to standard anticoagulation for iliofemoral venous thrombosis
mproved the long-term prevalence of PTS after iliofemoral DVT. This was
n open-label, randomized, controlled trial. Patients (aged 18-75 years)
ere recruited from 20 hospitals in southeastern Norway. To be included,
he DVT had to be a first-time iliofemoral DVT and patients had to be
ntered into the study21 days of symptom onset. Patients were randomly
ssigned to conventional treatment alone or CDT with alteplase. Random-
zation was stratified for involvement of pelvic veins. The two primary
utcomes were frequency of PTS, as assessed by the Villalta score at 24
onths, and iliofemoral venous patency at 6 months. An intention-to-treat
nalysis was used. There were 209 patients randomly assigned to the
reatment groups (108 to control and 101 to CDT). At 24 months,
ollow-up data for clinical status was available in 189 patients (95%: 99
ontrols, 90 CDTs), and 37 patients (41.1%, 95% confidence interval [CI]
1.5%-51.4%) allocated to additional CDT presented with PTS compared
ith 55 (55.6%, 95%CI, 45.7%-65.0%) in the control group (P .047). The
ifference in PTS corresponds to an absolute risk reduction of 14.4% (95%
I, 0.2%-27.9%), and the number needed to treat was seven (95% CI,
-502). At 6 months, iliofemoral patency was reported in 58 patients
65.9%, 95% CI, 55.5%-75.0%) in the CDT group vs 45 (47.4%, 95% CI,
7.6%-57.3%) in the control group (P  .012). There were 20 bleeding
omplications related to CDT, including three major and five clinically
elevant bleeding events.
Comment: This is the first large randomized trial to show clinically
ignificant reductions in PTS after the use of CDT compared with conven-
ional treatment alone for patients with acute iliofemoral DVT. The effect
as modest, with an absolute risk reduction of 14.4% and a number needed
o treat of seven to prevent one PTS. There was a small additional risk of
leeding in patients treated with CDT. Overall however, the results are
linically significant and support recent guidelines that CDT can be consid-
red in patients with proximal DVT and a low risk of bleeding.Adapted from Moneta G et al. 2012 Year Book of Vascular Surgery.
hiladelphia, PA: Elsevier; 2012; with permission.
